We are proposing a new pipeline that can predict novel and more accurate neoantigens for pediatric brain tumors using an approach independent from the assembled genomes. This project helps support current efforts being made to implement immunotherapy for this type of childhood tumors.
Get the Latest
news, articles, and resources sent to your inbox.
